These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 22958932)

  • 61. MHY1485 enhances X-irradiation-induced apoptosis and senescence in tumor cells.
    Sun L; Morikawa K; Sogo Y; Sugiura Y
    J Radiat Res; 2021 Sep; 62(5):782-792. PubMed ID: 34265852
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The correlation between epidermal growth factor levels in saliva and the severity of oral mucositis during oropharyngeal radiation therapy.
    Epstein JB; Gorsky M; Guglietta A; Le N; Sonis ST
    Cancer; 2000 Dec; 89(11):2258-65. PubMed ID: 11147596
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Rapamycin and the inhibition of the secretory phenotype.
    Wang R; Sunchu B; Perez VI
    Exp Gerontol; 2017 Aug; 94():89-92. PubMed ID: 28167236
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism.
    Wang R; Yu Z; Sunchu B; Shoaf J; Dang I; Zhao S; Caples K; Bradley L; Beaver LM; Ho E; Löhr CV; Perez VI
    Aging Cell; 2017 Jun; 16(3):564-574. PubMed ID: 28371119
    [TBL] [Abstract][Full Text] [Related]  

  • 65. PI3K/mTOR inhibitor PF-04691502 antitumor activity is enhanced with induction of wild-type TP53 in human xenograft and murine knockout models of head and neck cancer.
    Herzog A; Bian Y; Vander Broek R; Hall B; Coupar J; Cheng H; Sowers AL; Cook JD; Mitchell JB; Chen Z; Kulkarni AB; Van Waes C
    Clin Cancer Res; 2013 Jul; 19(14):3808-19. PubMed ID: 23640975
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Eukaryotic initiation factor 2α--a downstream effector of mammalian target of rapamycin--modulates DNA repair and cancer response to treatment.
    Tuval-Kochen L; Paglin S; Keshet G; Lerenthal Y; Nakar C; Golani T; Toren A; Yahalom J; Pfeffer R; Lawrence Y
    PLoS One; 2013; 8(10):e77260. PubMed ID: 24204783
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Protective effects of Korean red ginseng against radiation-induced apoptosis in human HaCaT keratinocytes.
    Chang JW; Park KH; Hwang HS; Shin YS; Oh YT; Kim CH
    J Radiat Res; 2014 Mar; 55(2):245-56. PubMed ID: 24078877
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Daily Time of Radiation Treatment Is Associated with Subsequent Oral Mucositis Severity during Radiotherapy in Head and Neck Cancer Patients.
    Gu F; Farrugia MK; Duncan WD; Feng Y; Hutson AD; Schlecht NF; Repasky EA; Antoch MP; Miller A; Platek A; Platek ME; Iovoli AJ; Singh AK
    Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):949-955. PubMed ID: 32098893
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Potential anti-aging agents suppress the level of constitutive mTOR- and DNA damage- signaling.
    Halicka HD; Zhao H; Li J; Lee YS; Hsieh TC; Wu JM; Darzynkiewicz Z
    Aging (Albany NY); 2012 Dec; 4(12):952-65. PubMed ID: 23363784
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intestinal stem cells acquire premature senescence and senescence associated secretory phenotype concurrent with persistent DNA damage after heavy ion radiation in mice.
    Kumar S; Suman S; Fornace AJ; Datta K
    Aging (Albany NY); 2019 Jun; 11(12):4145-4158. PubMed ID: 31239406
    [TBL] [Abstract][Full Text] [Related]  

  • 71. mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers.
    Bouamar H; Broome LE; Lathrop KI; Jatoi I; Brenner AJ; Nazarullah A; Gorena KM; Garcia M; Chen Y; Kaklamani V; Sun LZ
    Breast Cancer Res; 2023 Oct; 25(1):131. PubMed ID: 37904250
    [TBL] [Abstract][Full Text] [Related]  

  • 72. C-reactive protein levels and radiation-induced mucositis in patients with head-and-neck cancer.
    Ki Y; Kim W; Nam J; Kim D; Park D; Kim D
    Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):393-8. PubMed ID: 19362778
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Intraoral manganese superoxide dismutase-plasmid/liposome (MnSOD-PL) radioprotective gene therapy decreases ionizing irradiation-induced murine mucosal cell cycling and apoptosis.
    Epperly MW; Carpenter M; Agarwal A; Mitra P; Nie S; Greenberger JS
    In Vivo; 2004; 18(4):401-10. PubMed ID: 15369176
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of schedule duration on head and neck radiotherapy: accelerated tumor repopulation versus compensatory mucosal proliferation.
    Fenwick JD; Pardo-Montero J; Nahum AE; Malik ZI
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):1021-30. PubMed ID: 21377280
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Modulation of radiation-induced oral mucositis by thalidomide : Preclinical studies.
    Frings K; Gruber S; Kuess P; Kleiter M; Dörr W
    Strahlenther Onkol; 2016 Aug; 192(8):561-8. PubMed ID: 27282278
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Protective Effects of N-Acetylcysteine against Radiation-Induced Oral Mucositis In Vitro and In Vivo.
    Kim HJ; Kang SU; Lee YS; Jang JY; Kang H; Kim CH
    Cancer Res Treat; 2020 Oct; 52(4):1019-1030. PubMed ID: 32599978
    [TBL] [Abstract][Full Text] [Related]  

  • 77. mTOR inhibitors show promising in vitro activity in bladder cancer and head and neck squamous cell carcinoma.
    Schedel F; Pries R; Thode B; Wollmann B; Wulff S; Jocham D; Wollenberg B; Kausch I
    Oncol Rep; 2011 Mar; 25(3):763-8. PubMed ID: 21240463
    [TBL] [Abstract][Full Text] [Related]  

  • 78. 5-methoxytryptophan protects MSCs from stress induced premature senescence by upregulating FoxO3a and mTOR.
    Chang TC; Hsu MF; Shih CY; Wu KK
    Sci Rep; 2017 Sep; 7(1):11133. PubMed ID: 28894133
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Targeting mTOR by CZ415 Inhibits Head and Neck Squamous Cell Carcinoma Cells.
    Xie J; Li Q; Ding X; Gao Y
    Cell Physiol Biochem; 2018; 46(2):676-686. PubMed ID: 29621758
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mammalian target of rapamycin is a therapeutic target for murine ovarian endometrioid adenocarcinomas with dysregulated Wnt/β-catenin and PTEN.
    Tanwar PS; Zhang L; Kaneko-Tarui T; Curley MD; Taketo MM; Rani P; Roberts DJ; Teixeira JM
    PLoS One; 2011; 6(6):e20715. PubMed ID: 21695255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.